Ning-ping Zhang

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

K. Simon, R. Idilman, H. Janssen, 2015, Hepatology.

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

H. Janssen, B. Hansen, J. Reijnders, 2010, Gastroenterology.

Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China.

Jin-hui Yang, Defu Tian, Yu-lan Liu, 2013, World journal of gastroenterology.

Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial

J. Bajaj, Xuan Zhu, J. Shang, 2019, Journal of digestive diseases.

Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON)

R. D. de Knegt, H. Janssen, Liang Chen, 2017, The Journal of infectious diseases.

Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up

K. Simon, R. Idilman, R. D. de Knegt, 2018, Journal of viral hepatitis.

Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium.

Hai Helen Li, Chuanwu Zhu, P. Hayes, 2023, The lancet. Gastroenterology & hepatology.

Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.

H. Janssen, B. Hansen, J. Reijnders, 2010, Gastroenterology.